Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»HealthCare»TransCanna Completes Acquisition of 196,000 Square Foot Vertically Integrated Cannabis Facility
    HealthCare

    TransCanna Completes Acquisition of 196,000 Square Foot Vertically Integrated Cannabis Facility

    Marie JonesBy Marie JonesApril 17, 2019No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    (ACN Newswire) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it completed the purchase of a 196,000 square foot vertically integrated cannabis facility.

    “A tremendous effort by the TransCanna team on closing arguably the largest vertically integrated cannabis focused facility in California,” stated Jim Pakulis, CEO of TransCanna. “Simultaneous to putting our efforts into purchasing the facility, we’ve been searching extensively for the key individuals who will be overseeing the day to day operations. We’ve made great strides over the past several weeks and should be able to start making announcements by the end of the month.”

    The total purchase price for the Property was US$15 million. The Company’s CEO paid the seller a US$250,000 non-refundable deposit to secure the property, which has since been reimbursed by the Company, and the Company will pay an US$8 million down payment from the proceeds of the Company’s over-subscribed brokered private placement once closed (see news releases dated February 20, 2019 and March 14, 2019). In consideration of the issuance of 500,000 common shares of the Company, the seller of the building agreed to a carry back note of US$6.750 million at 7% p.a. interest only for up to thirteen months, with an initial maturity date of October 15, 2019, subject to a six-month extension. See March 20th press release for additional terms.

    The Company has also issued to the seller 1,200,000 share purchase warrants exercisable to acquire a common share of the Company at an exercise price of $2.60 per share until April 15, 2024, vesting in equal quarterly portions over a 12-month period commencing on February 21, 2019, notwithstanding the warrants were issued today.

    Additionally, a success fee of up to 2,000,000 common shares was paid to Haywood Securities Inc. in consideration of financial advisory services being provided to the Company in connection with the facility acquisition.

    All of the securities issuable to the seller or Haywood Securities Inc. in connection with the facility acquisition are subject to a four month hold period ending on August 16, 2019 as well as applicable restrictions under U.S. securities laws.

    For further information, please visit the Company’s website at www.transcanna.com.

    About TransCanna Holdings Inc.
    TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

    Media Contact
    TransCanna@talkshopmedia.com
    Telephone: +1-604-738-2220

    On behalf of the Board of Directors
    James Pakulis
    Chief Executive Officer
    Telephone: +1-604-609-6199

    The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results may differ materially from those anticipated and indicated by these forward looking statements. Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. 

    TransCanna Holdings Inc.
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleGlenBit Exchange Announces Integration with Blockpass KYC Connect
    Next Article NIST testing ranks TECH5 among the world’s best performing Face Recognition Algorithms

    Related Posts

    ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801’s Renoprotective Potential in Oral Presentation

    June 5, 2026

    Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

    June 4, 2026

    Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

    June 4, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.